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Immunoblotting combined with radioimmunoassays (RIAs) directed specifically towards certain sequences 
of the proenkephalin molecule has been used to characterize the enkephalin-containing peptides (ECPs) 
present in the bovine adrenal medulla. Immunoblotting allowed the simultaneous visualization of all ECPs 
present in a crude extract of this gland. Combining this technique with RIAs we have been able to 
characterize a new high molecular mass ECP, a 23.3-kDa protein which contains the amino-terminal part 
of proenkephalin and ends with the sequence of Leu-enkephalin at its carboxy-terminus. 
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1. INTRODUCTION 
Several enkephalin-containing peptides (ECPs) 
have been isolated from the bovine adrenal 
medulla [l-6]. These peptides have been proposed 
to represent intermediates in the processing of pro- 
enkephalin, the polyenkephalin precursor [7-91. 
Proenkephalin contains 4 copies of Met- 
enkephalin and one copy each of Leu-enkephalin, 
the heptapeptide (Met-enkephalin-Arg6-Phe’) and 
the octapeptide (Met-enkephalin-Arg6-Gly’-Leu’) 
(fig.1) [IO-121. The sequences of Met-enkephalin, 
Leu-enkephalin and the octapeptide are bracketed 
by pairs of basic amino acids (Lys or Arg) and the 
sequence of the heptapeptide, which is located at 
the carboxyl terminal of proenkephalin, is preced- 
ed by a pair of basic amino acids. 
The 3 largest ECPs isolated so far from the 
adrenal medulla (8.6, 12.6 and 18.2 kDa) have 
been completely sequenced by classical methods. 
They all contain the amino-terminal fragment of 
proenkephalin. The largest molecule (18.2 kDa) 
contains 3 copies of the Met-enkephalin sequence 
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and ends at the carboxyl terminal with the se- 
quence of the octapeptide. The 12.6- and 8.6-kDa 
proteins contain 3 and 1 copy of the Met- 
enkephalin sequence, respectively (fig. 1). 
Here we have used immunoblotting in combina- 
tion with RIAs to identify these previously 
characterized proteins in crude tissue extracts. In 
addition, two as yet undescribed ECPs were also 
observed. The largest of these, the 23.3-kDa pro- 
tein, begins with the amino-terminal sequence of 
proenkephalin and ends with the sequence of Leu- 
enkephalin (fig. 1). 
2. MATERIALS AND METHODS 
2.1. Tissue preparation and electrophoresis 
Bovine adrenal glands were obtained fresh from 
a local slaughterhouse and transported on ice to 
the laboratory. The medullae were dissected out 
and boiled for 20 min in 5 vols of 1 M acetic acid 
adjusted to pH 1.9 with HCI. The tissue was 
homogenized with a polytron and centrifuged for 
1 h at 20000 x g. The supernatant was lyophilized 
and resuspended in electrophoresis sample buffer. 
Polyacrylamide gel electrophoresis was performed 
as in [ 131 with a stacking gel of 4% acrylamide and 
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Fig.1. Proenkephalin and the enkephalin-containing 
peptides in the bovine adrenal medulla. The complete 
sequence of proenkephalin (27.3 kDa), which is 
represented schematically on the top of the figure, has 
been deduced from the corresponding cDNA [lo-121. 
This protein has never been isolated from the adrenal 
medulla. The largest ECPs isolated so far, 18.2, 12.6 and 
8.6 kDa, contain the N-terminal part of proenkephalin 
[4-61. The new 23.3-kDa intermediate characterized 
here also contains this N-terminal part. Peptides F, 
5.3 K, I, E and B are small ECPs which have been 
purified to homogeneity and sequenced [8,9]. M, Met- 
enkephalin; 0, octapeptide; L, Leu-enkephalin; H, 
heptapeptide. 
a resolving gel of 12% acrylamide, with the addi- 
tion of 5 M urea in both gels. 
2.2. Immunochemical visualization 
Following electrophoresis, proteins were 
transferred electrophoretically to nitrocellulose 
paper in a transblot cell (Bio-Rad) (3 h; 55 V; 
0.3 A with cooling to 4OC). The paper was 
prepared for immunochemical visualization of the 
antigen essentially as in [14], which included a 
10 min rinse in 50 mM Tris-HCl, 200 mM NaCl, 
0.02~a NaN3 (pH 7.4) (TBS), foIlowed by a 1 h in- 
cubation in the same buffer plus 3% bovine serum 
albumin (TBSA) to saturate the protein binding 
capacity of the paper. The paper was cut into strips 
and incubated overnight at 4OC with 1 of the 3 
primary antisera described below. After a 30 min 
rinse in TBSA, the paper was incubated for 2 h 
with sheep affinity-purified anti-rabbit IgG which 
had been coupled to horseradish peroxidase (In- 
stitut Pasteur, Paris). Following a 10 min rinse in 
TBS with the NaCl concentration increased to 
0.5 M and a 20 min rinse in TBS, the 
IgG-peroxidase complexes were visualized by 
revealing the peroxidase activity with 4-chloro- 
1-naphthol (3 mM in TBS) in the presence of 
0.01% HtOz. 
The Met-enkephalin and octapeptide antisera 
used here were directed specifically towards the C- 
terminal part of the corresponding peptides. The 
Met-enkephalin antiserum (AC2158) was used at a 
I/ 1000 final dilution and exhibited 10% cross- 
reactivity with Leu-enkephalin and less than 5% 
cross-reactivity with the heptapeptide and the oc- 
tapeptide in RIA [IS]. The octapeptide antiserum 
(AC2227) was used at a l/1000 final dilution and 
cross-reacted less than 0.1% with Met-enkephalin, 
Leu-enkephalin and the heptapeptide in RIA 1161. 
The synenkephalin antiserum was directed against 
the N-terminal l-70 sequence of proenkephalin 
(synenkephalin) and recognizes neither the Met- 
enkephalin sequence nor ECPs which do not con- 
tain the N-terminal fragment [17]. It was used at a 
1 /SO0 final dilution. 
2.3. Proteolytic digestion and extraction of ECPs 
To characterize further the ECPs visualized by 
immunochemical techniques, lanes of nitrocellu- 
lose paper were cut into 2-mm slices. These slices 
were then treated with trypsin alone (Trypsin 
TPCK, Worthington; final cont. 1OOpglml in 
0.4 ml of SO mM Tris-HCl buffer, pH 8.4, con- 
taining 2 mM CaCl2; 16 h incubation at 37°C) or 
trypsin followed by carboxypeptidase B (Boehr- 
inger Mannheim; final cont. 0.1 fig/ml in 0.5 ml 
of SO mM Tris-HCI buffer, pH 8.4, containing 
2 mM CaC12; 1 h incubation at 37°C). After the 
trypsin digestion only those enkephalin sequences 
located at the C-terminal end of ECPs would be 
expected to be released in a form recognized by our 
enkephalin antisera, i.e., without C-terminal ex- 
tension The other enkephalin sequences released 
by this treatment would contain C-terminal Arg or 
Lys residues, and thus would not be recognized by 
the enkephalin antisera. The subsequent digestion 
with carboxypeptidase B, which removes the C- 
terminal basic amino acids, would generate en- 
kephalin. Another Iane was cut into l-mm slices 
which were treated with protease V8 from Sta- 
phylococcus aureus (strain V8) which specifically 
cleaves the peptide bonds at the carboxyl side of 
glutamic or aspartic acid (Miles Laboratories; final 
cont. 80 pglml in 0.5 ml of 50 mM Tris-HCl buf- 
fer, pH 7.8; 16 h incubation at 37°C) [18]. The 
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digestion with S. aureus protease was expected to 
produce the dodecapeptide Val-Ser-Lys-Arg-Tyr- 
sly-sly-Phe-Met-Arg-~iy-Leu from larger ECPs 
containing at their C-terminai end the sequence of 
the octapeptide. 
2.4. Radioimmunoassays 
After the proteolytic treatment Leu-enkephalin 
immunoreactivity (IR) was determined using an 
antiserum directed towards the C-terminal end of 
Leu-enkephalin, which cross-reacted less than 5% 
with Met-enkephalin [ 191. Met-enkephalin IR and 
octapeptide IR were determined using the antisera 
described above [ 15, i 61. 
3. RESULTS 
3.1. Characterization of the 23.3-kDa 
intermediate 
After immunoblotting of a crude adrenal ex- 
tract, 6 bands corresponding to proteins of 26, 23, 
19, 13, 6 and 4 kDa were stained with the Met- 
enkephalin antiserum (fig.2, lane 1). These bands 
are numbered l-6 in fig.2. The protein correspon- 
ding to band 1 was also stained by the 
synenkephalin antiserum, which recognizes all the 
intermediates containing the N-terminal fragment 
of proenkephalin (synenkephalin) (fig.2, lane 2). 
The octapeptide antiserum did not stain this pro- 
tein (fig.2, lane 3). 
To characterize further this protein observed 
with immunostaining, we used RIA techniques. 
While digestion of band I by trypsin alone did not 
generate significant amounts of Met-enkephalin- 
IR, subsequent reatment by carboxypeptidase B 
enhanced it markedly (fig.3A). Trypsin treatment 
alone induced the appearance of a large amount of 
Leu-enkephalin-IR which was not increased fur- 
ther by the subsequent carboxypeptidase B treat- 
ment (fig.3B). No octapeptide-IR was detected 
after treatment of band 1 with the protease of S. 
aureus (fig.4). Therefore, the protein correspon- 
ding to band 1, which is stained by both Met- 
enkephalin and synenkephalin antisera, appears to 
contain the Leu-enkephalin sequence at its carboxy 
terminus. From these data and given its apparent 
M,, this protein is the largest intermediate in the 
processing of proenkephalin which has been 
characterized so far in the adrenal medulla. This 
protein, proenkeph~in (l-206), has a calculated 
l- 
2- 
3- 
5- 
6- 
lane No 1 2 3 
Fig.2. Immunoblotting of a crude adrenal extract. 
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Following electrophoresis the proteins of an adrenal 
extract were transferred to a nitrocellulose paper. This 
paper was cut Iongitudinahy in 3 lanes which were 
stained with ~ti-Met-enkephal~n serum (lane l), anti- 
synenkephalin serum (lane 2) and anti-octapeptide 
serum (lane 3). The standards run in parallel were: 
ovalbumin (43 kDa), carbonic anhydrase (30 kDa), 
soybean trypsin inhibitor (21 kDa), cytochrome c 
(13 kDa) and aprotinin (6 kDa). 
M, of 23300. 
3.2. Identification of the l&2-kDa enkephalin- 
containing protein 
The proteins corresponding to bands 2 and 3 
were stained simultaneously by the Met- 
enkephalin, octapeptide and synenkephalin an- 
tisera (fig.2, lanes 1-3). After processing of the 
nitrocellulose paper for RIA both bands exhibited 
substantial amounts of Met-enkephalin-IR but no 
Leu~nkephalin-IR was detectable (fig.3A and B), 
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Fig.3. Profile of Met-enkephalin and Leu-enkephalin 
immunoreactivities following digestion of the 
immunoblot presented in fig.2. Met- and Leu- 
enkephalin-IR of 2-mm slices were determined by RIAs 
after digestion with trypsin alone (M) or trypsin 
followed by carboxypeptidase B (o -. -0). From the 
total amount of Met-enkephalin-IR loaded on each lane 
(0.5 nmol) and the amount recovered after the digestion 
of the paper with trypsin and carboxypeptidase B 
(0.18 nmol), an overall yield of 37% has been calculated 
for the recovery of total Met-enkephalin. 
The pattern of octapeptide-IR obtained by RIA 
after digestion with the protease of S. aureus was 
in good agreement with that obtained by staining. 
The highest amount of octapeptide-IR correspond- 
ed to the protein which exhibited the most intense 
staining while the other high M, protein contained 
July 1984 
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Fig.4. Profile of octapeptide immunoreactivity 
following digestion of the immunoblot presented in 
fig.2. Octapeptide immunoreactivity of l-mm slices was 
determined by RIA after digestion with S. uuwus V8 
protease. 
a much loqer amount of octapeptide-IR (fig.4). 
Given the high specificity of the octapeptide an- 
tiserum towards the C-terminal part of this pep- 
tide, it appears from our data that the adrenal 
medulla probably contains two distinct forms of 
the previously purified 18.2 kDa intermediate, 
which contains the N-terminal part of pro- 
enkephalin and terminates with the sequence of the 
octapeptide at its carboxyl end. The intermediate 
of lower apparent molecular mass (band 3), which 
is the predominant form, probably represents the 
18.2-kDa intermediate reported previously which 
has been shown not to be glycosylated [20]. The 
higher molecular mass intermediate (band 2) could 
conceivably represent a glycosylated derivative of 
the 18.2-kDa protein, although this clearly needs 
further support. 
3.3. Visualization of the 12.6 and 8.dklla 
intermediates 
The proteins corresponding to bands 4 and 5 
were strongly stained both by Met-enkephalin and 
synenkephalin antisera. Digestion of these bands 
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with trypsin alone revealed the presence of a Met- 
enkephalin sequence at the carboxyl end of both 
proteins. While the Met-enkephalin-IR of band 4 
was increased 280% by further treatment with car- 
boxypeptidase B, indicating that the corresponding 
protein probably contains 3 copies of Met- 
enkephalin, the immunoreactivity of band 5 was 
not changed by this treatment, indicating that the 
corresponding protein contains a single copy of 
Met-enkephalin. Given their molecular masses, 
staining and immunoreactivity patterns, the pro- 
teins corresponding to band 4 and band 5 probably 
represent, respectively, the 12.6-kDa and 8.6-kDa 
intermediates which have been purified from 
adrenal medulla [5]. 
3.4. Visualization of low M, ECPs 
Band 6 represents in fact two very faint bands 
corresponding to low-M, (C 6000) peptides. These 
peptides were stained with the Met-enkephalin an- 
tiserum, but not with the synenkephalin antiserum 
or octapeptide antiserum. These two bands were 
not resolved by the slicing of the paper and appear 
after digestion as a large peak of enkephalin im- 
munoreactivity. In this peak Met-enkephalin-IR 
generated by the digestion with trypsin was in- 
creased by further treatment with carboxypep- 
tidase B, while Leu-enkephalin-IR was not 
changed significantly. Thus, given the pattern of 
staining, immunoreactivity and the low M,, these 
bands probably represent a mixture of small ECPs 
that may include peptides E, F, I and B. 
4. DISCUSSION 
Using immunoblotting combined with specific 
RIAs, we have been able to characterize new high 
M, intermediates in the processing of pro- 
enkephalin in the bovine adrenal medulla and to 
visualize simultaneously several other described 
ECPs. All of the largest ECPs (Mr > 8000) isolated 
from the bovine adrenal medulla to date have been 
shown by classical biochemical techniques to con- 
tain the N-terminal part of proenkephalin [4-61. 
The results obtained by immunoblotting are con- 
sistent with these data. All of the largest peptides 
containing Met-enkephalin immunoreactivity that 
were detected either by immunoblotting or by RIA 
are also stained by the synenkephalin antiserum, 
which is directed specifically towards the N- 
terminal part of proenkephalin [17]. 
Furthermore, we have described two new high 
molecular mass ECPs. The first one contains the 
sequence of the octapeptide at its C-terminus but 
appears larger than 18.2 kDa. The other novel 
peptide extends further towards the C-terminal end 
of proenkephalin, terminating with the sequence 
of Leu-enkephalin. These data are consistent with 
the proposal that the complete processing of pro- 
enkephalin in the adrenal medulla involves several 
successive proteolytic events starting at the carbox- 
yl terminal of this precursor [7-91. The combina- 
tion of immunoblotting with specific RIAs appears 
to be a powerful tool for the study of pro- 
enkephalin processing. It allows the simultaneous 
visualization and characterization of all in- 
termediates present in a crude extract of bovine 
adrenal medulla, and may be applied to study the 
products of proteolytic cleavage of proenkephalin 
by putative processing enzymes in vitro. 
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